id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2004-N-0252-0005,FDA,FDA-2004-N-0252,FDA,Notice,NAL-Notice of Approval,2004-12-06T05:00:00Z,2004,12,2004-11-30T05:00:00Z,,2008-04-12T00:40:16Z,,0,0,0900006480471b75
FDA-2004-N-0252-0004,FDA,FDA-2004-N-0252,Supporting Statement,Supporting & Related Material,SS-Supporting Statement,2004-12-06T05:00:00Z,2004,12,,,2008-04-12T00:40:16Z,,0,0,0900006480471b74
FDA-2004-N-0252-0003,FDA,FDA-2004-N-0252,Supporting Statement,Supporting & Related Material,SS-Supporting Statement,2004-12-06T05:00:00Z,2004,12,,,2008-04-12T00:40:16Z,,0,0,0900006480471b73
FDA-2004-N-0252-0002,FDA,FDA-2004-N-0252,FDA,Notice,N-Notice,2004-07-21T04:00:00Z,2004,7,2004-07-16T04:00:00Z,,2008-04-12T00:40:16Z,,0,0,0900006480471b72
FDA-2004-N-0252-0001,FDA,FDA-2004-N-0252,FDA,Notice,N-Notice,2004-02-26T05:00:00Z,2004,2,2004-02-25T05:00:00Z,2004-04-27T03:59:59Z,2008-04-12T00:40:16Z,,0,0,0900006480471b71